These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 29188501)

  • 81. NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer.
    Shibata T; Kokubu A; Saito S; Narisawa-Saito M; Sasaki H; Aoyagi K; Yoshimatsu Y; Tachimori Y; Kushima R; Kiyono T; Yamamoto M
    Neoplasia; 2011 Sep; 13(9):864-73. PubMed ID: 21969819
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Molecular Marker Expression Is Highly Heterogeneous in Esophageal Adenocarcinoma and Does Not Predict a Response to Neoadjuvant Therapy.
    Bronson NW; Diggs BS; Bakis G; Gatter KM; Sheppard BC; Hunter JG; Dolan JP
    J Gastrointest Surg; 2015 Dec; 19(12):2105-10. PubMed ID: 26394876
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Multiple roles of single-minded 2 in esophageal squamous cell carcinoma and its clinical implications.
    Tamaoki M; Komatsuzaki R; Komatsu M; Minashi K; Aoyagi K; Nishimura T; Chiwaki F; Hiroki T; Daiko H; Morishita K; Sakai Y; Seno H; Chiba T; Muto M; Yoshida T; Sasaki H
    Cancer Sci; 2018 Apr; 109(4):1121-1134. PubMed ID: 29427302
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Effect of neoadjuvant chemoradiotherapy on p53 and SOX2 protein expression in esophageal adenocarcinoma.
    Suzuki L; Nieboer D; van Lanschot JJ; Spaander MC; Looijenga LH; Biermann K
    Biomark Med; 2020 Jun; 14(9):785-793. PubMed ID: 32677456
    [No Abstract]   [Full Text] [Related]  

  • 85. Correlation between TXNRD1/HO-1 expression and response to neoadjuvant chemoradiation therapy in patients with esophageal squamous cell carcinoma.
    Akaishi R; Fujishima F; Ishida H; Tsunokake J; Yamauchi T; Gokon Y; Ueki S; Fukutomi T; Okamoto H; Takaya K; Sato C; Taniyama Y; Nakamura T; Nakaya N; Kamei T; Sasano H
    Esophagus; 2022 Jul; 19(3):436-443. PubMed ID: 34999996
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Prediction of response to neoadjuvant chemotherapy in carcinomas of the upper gastrointestinal tract.
    Höfler H; Langer R; Ott K; Keller G
    Recent Results Cancer Res; 2007; 176():33-6. PubMed ID: 17607914
    [TBL] [Abstract][Full Text] [Related]  

  • 87. High stathmin 1 expression is associated with poor prognosis and chemoradiation resistance in esophageal squamous cell carcinoma.
    Suzuki S; Yokobori T; Altan B; Hara K; Ozawa D; Tanaka N; Sakai M; Sano A; Sohda M; Bao H; Fukuchi M; Miyazaki T; Kaira K; Asao T; Kuwano H
    Int J Oncol; 2017 Apr; 50(4):1184-1190. PubMed ID: 28350065
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Response to chemoradiatiotherapy in squamous cell carcinoma of the esophagus: evaluation of some prognostic factors.
    Stockeld D; Falkmer U; Falkmer S; Backman L; Granström L; Fagerberg J
    Clin Exp Gastroenterol; 2009; 2():41-7. PubMed ID: 21694826
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Pan-endoscopic tumor length as the marker to predict response to neoadjuvant therapy for ESCC warrants additional investigation.
    Deng YF; Yuan TZ
    J Thorac Dis; 2018 Apr; 10(Suppl 9):S1122-S1123. PubMed ID: 29850193
    [No Abstract]   [Full Text] [Related]  

  • 90. HO-1 in lymph node metastasis predicted overall survival in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiation therapy.
    Akaishi R; Fujishima F; Ishida H; Tsunokake J; Yamauchi T; Gokon Y; Ueki S; Fukutomi T; Okamoto H; Takaya K; Sato C; Taniyama Y; Nakamura T; Nakaya N; Kamei T; Sasano H
    Cancer Rep (Hoboken); 2022 Mar; 5(3):e1477. PubMed ID: 34264023
    [TBL] [Abstract][Full Text] [Related]  

  • 91. GASC1-Adapted Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma: A Prospective Clinical Biomarker Trial.
    Jia R; Mi Y; Yuan X; Kong D; Li W; Li R; Wang B; Zhu Y; Kong J; Ma Z; Li N; Mi Q; Gao S
    J Oncol; 2020; 2020():1607860. PubMed ID: 32411232
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Nrf2 is useful for predicting the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
    Kawasaki Y; Okumura H; Uchikado Y; Kita Y; Sasaki K; Owaki T; Ishigami S; Natsugoe S
    Ann Surg Oncol; 2014 Jul; 21(7):2347-52. PubMed ID: 24599410
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Predictive value of p53 and 14-3-3sigma for the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
    Okumura H; Natsugoe S; Matsumoto M; Yokomakura N; Uchikado Y; Takatori H; Ishigami S; Takao S; Aikou T
    J Surg Oncol; 2005 Jul; 91(1):84-9. PubMed ID: 15999354
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Biomarkers for predicting the response of esophageal squamous cell carcinoma to neoadjuvant chemoradiation therapy.
    Okumura H; Uchikado Y; Setoyama T; Matsumoto M; Owaki T; Ishigami S; Natsugoe S
    Surg Today; 2014 Mar; 44(3):421-8. PubMed ID: 23605218
    [TBL] [Abstract][Full Text] [Related]  

  • 95. ABC Transporters and Their Role in the Neoadjuvant Treatment of Esophageal Cancer.
    Vrana D; Hlavac V; Brynychova V; Vaclavikova R; Neoral C; Vrba J; Aujesky R; Matzenauer M; Melichar B; Soucek P
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29543757
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Correlation Between Biomarker Candidate Proteins with the Effect of Neoadjuvant Chemoradiation Therapy on Esophageal Squamous Cell Carcinoma.
    Noda M; Okumura H; Uchikado Y; Omoto I; Sasaki K; Kita Y; Mori S; Owaki T; Arigami T; Uenosono Y; Nakajo A; Kijima Y; Ishigami S; Maemura K; Natsugoe S
    Ann Surg Oncol; 2018 Feb; 25(2):449-455. PubMed ID: 29188501
    [TBL] [Abstract][Full Text] [Related]  

  • 97. ERCC1 expression and tumor regression predict survival in esophageal squamous cell carcinoma patients receiving combined trimodality therapy.
    Ge H; Lu Y; Chen Y; Zheng X; Wang W; Yu J
    Pathol Res Pract; 2014 Oct; 210(10):656-61. PubMed ID: 25042384
    [TBL] [Abstract][Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.